These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 21910182)
21. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission. Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374 [TBL] [Abstract][Full Text] [Related]
22. Expression of HNF4γ is downregulated in patients with active ulcerative colitis (UC) compared to UC patients in remission and healthy controls. Bueno-Hernández N; Sánchez-Muñoz F; Barreto-Zuñiga R; Dominguez-López A; Yamamoto-Furusho JK Inflamm Bowel Dis; 2011 Aug; 17(8):E91. PubMed ID: 21618351 [No Abstract] [Full Text] [Related]
23. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations. Planell N; Lozano JJ; Mora-Buch R; Masamunt MC; Jimeno M; Ordás I; Esteller M; Ricart E; Piqué JM; Panés J; Salas A Gut; 2013 Jul; 62(7):967-76. PubMed ID: 23135761 [TBL] [Abstract][Full Text] [Related]
24. [Advances in the study of regulation of novel organic cation transporter-2]. Wang FR; Guo RC Yao Xue Xue Bao; 2009 Oct; 44(10):1061-5. PubMed ID: 20055125 [TBL] [Abstract][Full Text] [Related]
28. Human macrophage differentiation induces OCTN2-mediated L-carnitine transport through stimulation of mTOR-STAT3 axis. Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Milioli M; Di Lascia M; Bernuzzi G; Dall'Asta V J Leukoc Biol; 2017 Mar; 101(3):665-674. PubMed ID: 27733576 [TBL] [Abstract][Full Text] [Related]
29. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470 [TBL] [Abstract][Full Text] [Related]
30. Plasma carnitine ester profiles in Crohn's disease and ulcerative colitis patients with different IGR2230a_1 genotypes. Talián G; Lakner L; Bene J; Komlósi K; Horváth K; Gasztonyi B; Miheller P; Figler M; Mózsik G; Tulassay Z; Melegh B Int J Immunogenet; 2009 Dec; 36(6):329-35. PubMed ID: 19735486 [TBL] [Abstract][Full Text] [Related]
31. Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway. De Preter V; Arijs I; Windey K; Vanhove W; Vermeire S; Schuit F; Rutgeerts P; Verbeke K Inflamm Bowel Dis; 2012 Jun; 18(6):1127-36. PubMed ID: 21987487 [TBL] [Abstract][Full Text] [Related]
32. Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies. Macdonald C; Shao D; Oli A; Agu RU J Drug Target; 2013 Jan; 21(1):97-106. PubMed ID: 23050869 [TBL] [Abstract][Full Text] [Related]
33. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis. Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714 [TBL] [Abstract][Full Text] [Related]
34. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease. Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752 [TBL] [Abstract][Full Text] [Related]
35. High gene expression of MDR1 (ABCB1) is associated with medical treatment response and long-term remission in patients with ulcerative colitis. Yamamoto-Furusho JK; Villeda-Ramírez MA; Fonseca-Camarillo G; Sánchez-Muñoz F; Dominguez-Lopez A; Barreto-Zuñiga R; Uribe M Inflamm Bowel Dis; 2010 Apr; 16(4):541-2. PubMed ID: 19714749 [No Abstract] [Full Text] [Related]
36. In vivo evidence of organic cation transporter-mediated tracheal accumulation of the anticholinergic agent ipratropium in mice. Nakanishi T; Hasegawa Y; Haruta T; Wakayama T; Tamai I J Pharm Sci; 2013 Sep; 102(9):3373-81. PubMed ID: 23686692 [TBL] [Abstract][Full Text] [Related]
37. Pannexin-2 is expressed in the human colon with extensive localization in the enteric nervous system. Diezmos EF; Sandow SL; Perera DS; King DW; Bertrand PP; Liu L Neurogastroenterol Motil; 2015 May; 27(5):672-83. PubMed ID: 25773474 [TBL] [Abstract][Full Text] [Related]
38. Upregulated mRNA expression of major histocompatibility complex class I chain-related gene A in colon and activated natural killer cells of Chinese patients with ulcerative colitis. Ge LQ; Jiang T; Zhao J; Chen ZT; Zhou F; Xia B J Dig Dis; 2011 Apr; 12(2):82-9. PubMed ID: 21091928 [TBL] [Abstract][Full Text] [Related]
39. New therapeutic targets in ulcerative colitis: the importance of ion transporters in the human colon. Farkas K; Yeruva S; Rakonczay Z; Ludolph L; Molnár T; Nagy F; Szepes Z; Schnúr A; Wittmann T; Hubricht J; Riederer B; Venglovecz V; Lázár G; Király M; Zsembery Á; Varga G; Seidler U; Hegyi P Inflamm Bowel Dis; 2011 Apr; 17(4):884-98. PubMed ID: 20722063 [TBL] [Abstract][Full Text] [Related]
40. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis. Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]